Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.

MLA

Vukusic, Sandra, et al. “Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.” JAMA Neurology, vol. 77, no. 1, Jan. 2020, pp. 94–102. EBSCOhost, https://doi.org/10.1001/jamaneurol.2019.2670.

APA

Vukusic, S., Rollot, F., Casey, R., Pique, J., Marignier, R., Mathey, G., Edan, G., Brassat, D., Ruet, A., De Sèze, J., Maillart, E., Zéphir, H., Labauge, P., Derache, N., Lebrun-Frenay, C., Moreau, T., Wiertlewski, S., Berger, E., Moisset, X., … Laplaud, D.-A. (2020). Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France. JAMA Neurology, 77(1), 94–102. https://doi.org/10.1001/jamaneurol.2019.2670

Chicago

Vukusic, Sandra, Fabien Rollot, Romain Casey, Julie Pique, Romain Marignier, Guillaume Mathey, Gilles Edan, et al. 2020. “Progressive Multifocal Leukoencephalopathy Incidence and Risk Stratification Among Natalizumab Users in France.” JAMA Neurology 77 (1): 94–102. doi:10.1001/jamaneurol.2019.2670.